Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Brain Neoplasms × azeliragon × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Meningeal Carcinomatosis 1 Glioma 1 Glioblastoma 1 Cancer Related Cognitive Decline 1 Brain Neoplasms 1

Interventions

Radiosurgery 24 Magnetic Resonance Spectroscopy 20 pembrolizumab 10 Temozolomide 10 Bevacizumab 9 Specimen Handling 8 Nivolumab 6 Ipilimumab 6 Radiotherapy 5 Magnetic Resonance Imaging 5 Cyclophosphamide 5 Radiation 4 Neuropsychological Tests 4 Mental Status and Dementia Tests 4 Carboplatin 4 Capecitabine 4 fludarabine 3 fluciclovine F-18 3 encorafenib 3 abemaciclib 3 Proton Therapy 3 Etoposide 3 Dexamethasone 3 Blood Specimen Collection 3 Adrenal Cortex Hormones 3 trastuzumab deruxtecan 2 osimertinib 2 niraparib 2 fluoromisonidazole 2 binimetinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05789589 2026-03-04

ADORATION

Baptist Health South Florida

Phase 1/2 Recruiting

Brain Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡